Background: Autoimmune bullous diseases are rare conditions characterized by blistering of the skin and mucous membranes. The 2 commonest forms are pemphigus vulgaris and bullous pemphigoid. The oral cavity or oropharynx may be the initial site of presentation or often the only site involved. Summary: These conditions are often misdiagnosed or overlooked leading to poorer patient outcomes. Due to the chronic nature of these conditions and the systemic effects of treatment, there is a significant associated morbidity and mortality. As such, an understanding of the fundamentals of autoimmune bullous diseases is vital to those working in otolaryngology. The mainstay of management in both conditions is topical and systemic corticosteroids. There is also a role for immunomodulating and non-steroidal anti-inflammatory drugs as adjunct or alternative therapies. Surgical intervention may be required to protect the airway. Often multimodality treatment is required involving multidisciplinary input from otolaryngologists, oral surgeons, dermatologists, and rheumatologists. This review article will highlight the aetiology, pathology, clinical features, investigations, and management of both pemphigus vulgaris and bullous pemphigoid including recent advances in management.

1.
Diaz
LA
,
Giudice
GJ
.
End of the century overview of skin blisters
.
Arch Dermatol
.
2000 Jan
;
136
(
1
):
106
12
. .
2.
Langan
SM
,
Smeeth
L
,
Hubbard
R
,
Fleming
KM
,
Smith
CJ
,
West
J
.
Bullous pemphigoid and pemphigus vulgaris – incidence and mortality in the UK: population based cohort study
.
BMJ
.
2008 Jul
;
337
:
a180
. .
3.
Delgado
JC
,
Hameed
A
,
Yunis
JJ
,
Bhol
K
,
Rojas
AI
,
Rehman
SB
,
Pemphigus vulgaris autoantibody response is linked to HLA-DQB1*0503 in Pakistani patients
.
Hum Immunol
.
1997 Oct
;
57
(
2
):
110
9
. .
4.
Gil
JM
,
Weber
R
,
Rosales
CB
,
Rodrigues
H
,
Sennes
LU
,
Kalil
J
,
Study of the association between human leukocyte antigens (HLA) and pemphigus vulgaris in Brazilian patients
.
Int J Dermatol
.
2017 May
;
56
(
5
):
557
62
. .
5.
Ahmed
AR
,
Yunis
EJ
,
Khatri
K
,
Wagner
R
,
Notani
G
,
Awdeh
Z
,
Major histocompatibility complex haplotype studies in Ashkenazi Jewish patients with pemphigus vulgaris
.
Proc Natl Acad Sci USA
.
1990 Oct
;
87
(
19
):
7658
62
. .
6.
Todd
JA
,
Acha-Orbea
H
,
Bell
JI
,
Chao
N
,
Fronek
Z
,
Jacob
CO
,
A Molecular Basis for MHC Class II-Associated Autoimmunity
.
Science
.
1988
;
240
(
4855
):
1003
9
. .
7.
Lloyd-Lavery
A
,
Chi
CC
,
Wojnarowska
F
,
Taghipour
K
.
The associations between bullous pemphigoid and drug use: a UK case-control study
.
JAMA Dermatol
.
2013 Jan
;
149
(
1
):
58
62
. .
8.
Bastuji-Garin
S
,
Joly
P
,
Lemordant
P
,
Sparsa
A
,
Bedane
C
,
Delaporte
E
,
Risk factors for bullous pemphigoid in the elderly: a prospective case-control study
.
J Invest Dermatol
.
2011 Mar
;
131
(
3
):
637
43
. .
9.
Stanley
JR
,
Amagai
M
.
Pemphigus, bullous impetigo, and the staphylococcal scalded-skin syndrome
.
N Engl J Med
.
2006 Oct
;
355
(
17
):
1800
10
. .
10.
Hammers
CM
,
Stanley
JR
.
Mechanisms of disease: pemphigus and bullous pemphigoid
.
Annu Rev Pathol
.
2016 May
;
11
:
175
97
. .
11.
Chitaev
NA
,
Troyanovsky
SM
.
Direct Ca2+ -dependent heterophilic interaction between desmosomal cadherins, desmoglein and desmocollin, contributes to cell-cell adhesion
.
J Cell Biol
.
1997 Jul
;
138
(
1
):
193
201
. .
12.
Amber
KT
,
Valdebran
M
,
Grando
SA
.
Non-desmoglein antibodies in patients with pemphigus vulgaris
.
Front Immunol
.
2018
;
9
:
1190
. .
13.
Mariotti
F
,
Grosso
F
,
Terracina
M
,
Ruffelli
M
,
Cordiali-Fei
P
,
Sera
F
,
Development of a novel ELISA system for detection of anti-BP180 IgG and characterization of autoantibody profile in bullous pemphigoid patients
.
Br J Dermatol
.
2004 Nov
;
151
(
5
):
1004
10
. .
14.
Hale
EK
,
Bystryn
JC
.
Laryngeal and nasal involvement in pemphigus vulgaris
.
J Am Acad Dermatol
.
2001 Apr
;
44
(
4
):
609
11
. .
15.
Harman
KE
,
Brown
D
,
Exton
LS
,
Groves
RW
,
Hampton
PJ
,
Mohd Mustapa
MF
,
British association of dermatologists’ guidelines for the management of pemphigus vulgaris 2017
.
Br J Dermatol
.
2017
;
177
(
5
):
1170
201
. .
16.
Brenner
S
,
Tur
E
,
Shapiro
J
,
Ruocco
V
,
D’Avino
M
,
Ruocco
E
,
Pemphigus vulgaris: environmental factors. Occupational, behavioral, medical, and qualitative food frequency questionnaire
.
Int J Dermatol
.
2001 Sep
;
40
(
9
):
562
9
. .
17.
Bernard
P
,
Antonicelli
F
.
Bullous pemphigoid: a review of its diagnosis, associations and treatment
.
Am J Clin Dermatol
.
2017 Aug
;
18
(
4
):
513
28
. .
18.
Venning
VA
,
Taghipour
K
,
Mohd Mustapa
MF
,
Highet
AS
,
Kirtschig
G
,
Hughes
JR
,
British association of dermatologists, guidelines for the management of bullous pemphigoid 2012
.
Br J Dermatol
.
2012 Dec
;
167
(
6
):
1200
14
. .
19.
Wieczorek
M
,
Czernik
A
.
Paraneoplastic pemphigus: a short review
.
Clin Cosmet Investig Dermatol
.
2016 Sep
;
9
:
291
5
. .
20.
Dagistan
S
,
Goregen
M
,
Miloglu
O
,
Cakur
B
.
Oral pemphigus vulgaris: a case report with review of the literature
.
J Oral Sci
.
2008 Sep
;
50
(
3
):
359
62
. .
21.
Mahmoud
A
,
Miziara
ID
,
Costa
KC
,
Santi
CG
,
Maruta
CW
,
Aoki
V
.
Laryngeal involvement in pemphigus vulgaris: a proposed classification
.
J Laryngol Otol
.
2012 Oct
;
126
(
10
):
1041
4
. .
22.
España
A
,
Fernández
S
,
del Olmo
J
,
Marquina
M
,
Pretel
M
,
Ruba
D
,
Ear, nose and throat manifestations in pemphigus vulgaris
.
Br J Dermatol
.
2007 Apr
;
156
(
4
):
733
7
. .
23.
Chang
S
,
Park
SJ
,
Kim
SW
,
Jin
MN
,
Lee
JH
,
Kim
HJ
,
Esophageal involvement of pemphigus vulgaris associated with upper gastrointestinal bleeding
.
Clin Endosc
.
2014 Sep
;
47
(
5
):
452
4
. .
24.
Kaplan
I
,
Hodak
E
,
Ackerman
L
,
Mimouni
D
,
Anhalt
GJ
,
Calderon
S
.
Neoplasms associated with paraneoplastic pemphigus: a review with emphasis on non-hematologic malignancy and oral mucosal manifestations
.
Oral Oncol
.
2004 Jul
;
40
(
6
):
553
62
. .
25.
Joly
P
,
Richard
C
,
Gilbert
D
,
Courville
P
,
Chosidow
O
,
Roujeau
JC
,
Sensitivity and specificity of clinical, histologic, and immunologic features in the diagnosis of paraneoplastic pemphigus
.
J Am Acad Dermatol
.
2000 Oct
;
43
(
4
):
619
26
. .
26.
Rocchetto
H
,
Miyamoto
D
,
Aoki
V
,
Maruta
CW
,
Santi
CG
.
Laryngeal involvement in paraneoplastic pemphigus associated with benign Brenner tumor
.
2016
[cited 2020 Dec 30]. Available from: https://observatorio.fm.usp.br/handle/OPI/25190
27.
Cho
JH
,
Kim
NJ
,
Ko
SM
,
Kim
C
,
Ahn
HK
,
Yun
J
,
A Case Report of Paraneoplastic Pemphigus Associated with Esophageal Squamous Cell Carcinoma
.
Cancer Res Treat
.
2013 Mar
;
45
(
1
):
70
3
. .
28.
Kimyai-Asadi
A
,
Jih
MH
.
Paraneoplastic pemphigus
.
Int J Dermatol
.
2001 Jun
;
40
(
6
):
367
72
. .
29.
Anhalt
GJ
.
Paraneoplastic pemphigus
.
J Investig Dermatol Symp Proc
.
2004 Jan
;
9
(
1
):
29
33
. .
30.
Paolino
G
,
Didona
D
,
Magliulo
G
,
Iannella
G
,
Didona
B
,
Mercuri
SR
,
Paraneoplastic Pemphigus: Insight into the Autoimmune Pathogenesis, Clinical Features and Therapy
.
Int J Mol Sci
.
2017 Nov
;
18
(
12
). .
31.
Didona
D
,
Maglie
R
,
Eming
R
,
Hertl
M
.
Pemphigus: current and future therapeutic strategies
.
Front Immunol
.
2019
;
10
:
1418
. .
32.
Martínez De Pablo
MI
,
Iranzo
P
,
Mascaró
JM
,
Llambrich
A
,
Baradad
M
,
Herrero
C
.
Paraneoplastic pemphigus associated with non-Hodgkin B-cell lymphoma and good response to prednisone
.
Acta Derm Venereol
.
2005
;
85
(
3
):
233
5
. .
33.
Yancey
KB
,
Egan
CA
.
Pemphigoid: clinical, histologic, immunopathologic, and therapeutic considerations
.
JAMA
.
2000 Jul
;
284
(
3
):
350
6
. .
34.
Kridin
K
,
Bergman
R
.
Assessment of the prevalence of mucosal involvement in bullous pemphigoid
.
JAMA Dermatol
.
2019 Feb
;
155
(
2
):
166
71
. .
35.
Maharshak
N
,
Sagi
M
,
Santos
E
,
Sprecher
E
,
Goldberg
I
.
Oesophageal involvement in bullous pemphigoid
.
Clin Exp Dermatol
.
2013 Apr
;
38
(
3
):
274
5
. .
36.
Said
S
,
Golitz
L
.
Vesiculobullous eruptions of the oral cavity
.
Otolaryngol Clin North Am
.
2011 Feb
;
44
(
1
):
133
60, vi
. .
37.
Shklar
G
,
McCarthy
PL
.
Oral lesions of mucous membrane pemphigoid. A study of 85 cases
.
Arch Otolaryngol
.
1971 Apr
;
93
(
4
):
354
64
. .
38.
Hafsi
W
,
Badri
T
.
Erythema Multiforme. StatPearls. Treasure Island (FL)
StatPearls Publishing
;
Treasure Island, FL, USA
,
2020
. [cited 2020 Dec 29]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK470259/.
39.
Waters
T
,
Chen
S
.
169 Erythema multiforme major with esophageal involvement
.
J Invest Med
.
2018 Jan
;
66
(
1
).
40.
Schiødt
M
.
Oral manifestations of lupus erythematosus
.
Int J Oral Surg
.
1984 Apr
;
13
(
2
):
101
47
.
41.
Nadorra
RL
,
Nakazato
Y
,
Landing
BH
.
Pathologic features of gastrointestinal tract lesions in childhood-onset systemic lupus erythematosus: study of 26 patients, with review of the literature
.
Pediatr Pathol
.
1987
;
7
(
3
):
245
59
. .
42.
Tanaka
H
,
Jimbo
Y
,
Iwane
K
,
Takata
R
,
Ikeda
A
,
Dougaki
M
,
A case of bullous systemic lupus erythematosus with sloughing esophagitis
.
Nihon Shokakibyo Gakkai Zasshi
.
2020
;
117
(
3
):
252
60
. .
43.
Rennie
CE
,
Dwivedi
RC
,
Khan
AS
,
Agrawal
N
,
Ziyada
W
.
Lichen planus of the larynx
.
J Laryngol Otol
.
2011 Apr
;
125
(
4
):
432
5
. .
44.
de Oliveira
JP
,
Uribe
NC
,
Abulafia
LA
,
Quintella
LP
.
Esophageal lichen planus
.
An Bras Dermatol
.
2015
;
90
(
3
):
394
6
.
45.
Kappius
RH
,
Ufkes
NA
,
Thiers
BH
.
Paraneoplastic Pemphigus
.
Treasure Island, FL, USA
StatPearls Publishing
;
2020
. [cited 2020 Dec 28]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK546694/.
46.
Bhogal
B
,
Wojnarowska
F
,
Black
MM
,
Xu
W
,
Levene
GM
.
The distribution of immunoglobulins and the C3 component of complement in multiple biopsies from the uninvolved and perilesional skin in pemphigus
.
Clin Exp Dermatol
.
1986
;
11
(
1
):
49
53
. .
47.
Murrell
DF
,
Dick
S
,
Ahmed
AR
,
Amagai
M
,
Barnadas
MA
,
Borradori
L
,
Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus
.
J Am Acad Dermatol
.
2008 Jun
;
58
(
6
):
1043
6
. .
48.
Czernik
A
,
Bystryn
JC
.
Kinetics of response to conventional treatment in patients with pemphigus vulgaris
.
Arch Dermatol
.
2008 May
;
144
(
5
):
682
3
. .
49.
Atzmony
L
,
Hodak
E
,
Leshem
YA
,
Rosenbaum
O
,
Gdalevich
M
,
Anhalt
GJ
,
The role of adjuvant therapy in pemphigus: a systematic review and meta-analysis
.
J Am Acad Dermatol
.
2015
;
73
(
2
):
264
71
. .
50.
Joly
P
,
Roujeau
JC
,
Benichou
J
,
Picard
C
,
Dreno
B
,
Delaporte
E
,
A comparison of oral and topical corticosteroids in patients with bullous pemphigoid
.
N Engl J Med
.
2002
;
346
(
5
):
321
7
. .
51.
Bystryn
J-C
,
Steinman
NM
.
The adjuvant therapy of pemphigus: an update
.
Arch Dermatol
.
1996
;
132
(
2
):
203
12
.
52.
Buchman
AL
.
Side effects of corticosteroid therapy
.
J Clin Gastroenterol
.
2001 Oct
;
33
(
4
):
289
94
. .
53.
Joly
P
,
Mouquet
H
,
Roujeau
JC
,
D'Incan
M
,
Gilbert
D
,
Jacquot
S
,
A single cycle of rituximab for the treatment of severe pemphigus
.
N Engl J Med
.
2007
;
357
(
6
):
545
52
. .
54.
Joly
P
,
Maho-Vaillant
M
,
Prost-Squarcioni
C
,
Hebert
V
,
Houivet
E
,
Calbo
S
,
First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial
.
Lancet
.
2017
;
389
(
10083
):
2031
40
. .
55.
Herrmann
G
,
Hunzelmann
N
,
Engert
A
.
Treatment of pemphigus vulgaris with anti-CD20 monoclonal antibody (rituximab)
.
Br J Dermatol
.
2003
;
148
(
3
):
602
3
. .
56.
Cooper
HL
,
Healy
E
,
Theaker
JM
,
Friedmann
PS
.
Treatment of resistant pemphigus vulgaris with an anti-CD20 monoclonal antibody (Rituximab)
.
Clin Exp Dermatol
.
2003
;
28
(
4
):
366
8
. .
57.
Goebeler
M
,
Herzog
S
,
Bröcker
EB
,
Zillikens
D
.
Rapid response of treatment-resistant pemphigus foliaceus to the anti-CD20 antibody rituximab
.
Br J Dermatol
.
2003
;
149
(
4
):
899
901
. .
58.
Izumi
K
,
Bieber
K
,
Ludwig
RJ
.
Current clinical trials in pemphigus and pemphigoid
.
Front Immunol
.
2019
;
10
. .
59.
Lunardon
L
,
Payne
AS
.
Inhibitory human antichimeric antibodies to rituximab in a patient with pemphigus
.
J Allergy Clin Immunol
.
2012 Sep
;
130
(
3
):
800
3
. .
60.
Rapp
M
,
Pentland
A
,
Richardson
C
.
Successful treatment of pemphigus vulgaris with ofatumumab
.
J Drugs Dermatol
.
2018 01
;
17
(
12
):
1338
9
.
61.
Satterthwaite
AB
,
Li
Z
,
Witte
ON
.
Btk function in B cell development and response.
Semin Immunol
.
1998;10(4)
:
309
16
.
62.
Lee
A
,
Sandhu
S
,
Imlay-Gillespie
L
,
Mulligan
S
,
Shumack
S
.
Successful use of Bruton’s kinase inhibitor, ibrutinib, to control paraneoplastic pemphigus in a patient with paraneoplastic autoimmune multiorgan syndrome and chronic lymphocytic leukaemia
.
Australas J Dermatol
.
2017
;
58
(
4
):
e240
2
. .
63.
Principia Biopharma Reports Positive PRN1008 Phase 2 Top-Line Results and Initiates Phase 3 Pemphigus Program | Principia Biopharma [Internet]
. [cited 2020 Aug 4]. Available from. https://ir.principiabio.com/news-releases/news-release-details/principia-biopharma-reports-positive-prn1008-phase-2-top-line/
64.
Toosi
S
,
Bystryn
JC
.
Potential role of interleukin-17 in the pathogenesis of bullous pemphigoid
.
Med Hypotheses
.
2010
;
74
(
4
):
727
8
. .
65.
Le Jan
S
,
Plée
J
,
Vallerand
D
,
Dupont
A
,
Delanez
E
,
Durlach
A
,
Innate immune cell-produced IL-17 sustains inflammation in bullous pemphigoid
.
J Invest Dermatol
.
2014
;
134
(
12
):
2908
17
. .
66.
Kar
P
.
Recent trends in the management of pemphigus vulgaris
.
Med J Armed Forces India
.
1998 Jul
;
54
(
3
):
243
6
. .
67.
Lakdawala
N
,
Babalola
O
,
Fedeles
F
,
McCusker
M
,
Ricketts
J
,
Whitaker-Worth
D
,
The role of nutrition in dermatologic diseases: facts and controversies
.
Clin Dermatol
.
2013 Dec
;
31
(
6
):
677
700
. .
68.
Saunders
MS
,
Gentile
RD
,
Lobritz
RW
.
Primary laryngeal and nasal septal lesions in pemphigus vulgaris
.
J Am Osteopath Assoc
.
1992 Jul
;
92
(
7
):
933
7
. .
69.
Bansal
M
.
Is laryngeal involvement in pemphigus vulgaris rare? A review
.
Int J Res Dermatol
.
2015 Dec
;
1
(
1
):
3
6
. .
70.
Iqbal
M
,
Ahmed
R
,
Kashef
SH
,
Bahame
PS
.
Laryngeal involvement in a patient with bullous pemphigoid
.
Ann Saudi Med
.
2006
;
26
(
2
):
152
4
. .
71.
Lazor
JB
,
Varvares
MA
,
Montgomery
WW
,
Goodman
ML
,
Mackool
BT
.
Management of airway obstruction in cicatricial pemphigoid
.
Laryngoscope
.
1996
;
106
(
8
):
1014
7
. .
72.
Jalil
BA
,
Abdou
YG
,
Rosen
SA
,
Dammad
T
.
Mucous membrane pemphigoid causing central airway obstruction
.
J Bronchology Interv Pulmonol
.
2017 Oct
;
24
(
4
):
334
8
. .
73.
Eliashar
R
,
Eliachar
I
,
Esclamado
R
,
Gramlich
T
,
Strome
M
.
Can topical mitomycin prevent laryngotracheal stenosis?
Laryngoscope
.
1999
;
109
(
10
):
1594
600
. .
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.